GT Medical Technologies Raises $100M to Expand GammaTile Radiotherapy Implant Commercialization

Deal Summary

GT Medical Technologies announced a $100 million fundraising round to support the commercialization and further clinical research of its GammaTile radiotherapy implant. The capital will be used to expand market reach and advance ongoing trials, underscoring investor confidence in the company's oncology platform.